Condition: Adrenal Insufficiency · Polymyalgia Rheumatica · Giant Cell Arteritis · Sponsor: Marianne Christina Klose
In this double-blinded randomised placebo-controlled clinical trial, the aim is to determine the effect of supplemental hydrocortisone compared with placebo during mild to moderate physical or mental stress on health related quality of life in patients with polymyalgia rheumatica (PMR)/giant cell arteritis (GCA) on ongoing low-dose prednisolone diagnosed with glucocorticoid-induced adrenal insufficiency. The main emphasis is on fatigue (primary outcome) and daily variation hereof during periods of stress.
This description comes directly from the study's public registry record.
Marianne Klose, MD, PhD · +4530237532 · marianne.christina.klose.01@regionh.dk
Stina W. Borresen, MD, PhD · +4525347551 · stina.borresen@regionh.dk
Always discuss trial participation with your own doctor first.
| Department of Endocrinology, Aarhus University Hospital | Aarhus, Denmark | Recruiting |
| Department of Medical Endocrinology, Copenhagen University Hospital, Rigshospitalet | Copenhagen, Denmark | Recruiting |
| Department of Endocrinology, Odense University Hospital | Odense, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05435781